Cell And Gene Therapy Clinical Trial Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: IQVIA, ICON Plc, Covance, PAREXEL International Corporation

The global Cell and Gene Therapy Clinical Trial market reached a value of US$ 7.9 billion in 2021. Looking ahead, the market is expected to reach $ 40.5 billion by 2027, growing at a CAGR of 20.5% between 2022 and 2027.

Cell And Gene Therapy Clinical Trial Market Overview

A number of potential treatments have been created worldwide as a result of cell and gene therapies (CGTs), which represent the next major wave in therapeutic innovation. Numerous promising medicines are now being developed worldwide, despite the fact that only a small number of early medications have received marketing approval in the United States. The market is primarily driven by increased R&D investment, rising patient demand for new therapeutics, expanding interest in cell and gene therapies for cancer therapy, and a favorable regulatory environment. A brand-new front in the battle against numerous fatal illnesses, such as malignancies and rare genetic disorders, is cell and gene therapy (CGT). It stands for the most recent round of innovation in the life sciences sector. Early in the 2020s, the COVID-19 pandemic decreased the number of gene therapy clinical trials because the majority of research was devoted to treating and identifying COVID-19.

Industry News and Updates:

Dec 13, 2021: Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021 --

Novartis today announced the introduction of T-Charge™, the company’s next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. At the 63rd American Society of Hematology Annual Meeting & Exposition (ASH) 2021, Novartis will present early clinical data from ongoing Phase I clinical trials with YTB323 (anti-CD19) and PHE885 (anti-BCMA), the first Novartis CAR-T cell therapies developed using this platform. Notably, initial efficacy data show a complete response rate of 73% (95% CI: 44.9, 92.2) at month three for the 15 patients with diffuse large B-cell lymphoma (DLBCL) who received dose level two of YTB3231. For the 11 patients with multiple myeloma who received the two highest doses of PHE885, the best overall response was 100%2.

What are the major Applications, Types and Regions for Cell And Gene Therapy Clinical Trial Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Phase I


• Phase II


• Phase III


• Phase IV

By Application, it is segmented into

• Oncology


• Cardiology


• CNS


• Musculoskeletal


• Infectious Diseases


• Dermatology


• Endocrine, Metabolic, Genetic


• Immunology & Inflammation


• Ophthalmology

Cell And Gene Therapy Clinical Trial Market Regional Analysis

North America accounted for 48.3% of worldwide sales in 2021 and is predicted to maintain its lead throughout the projection period. A favourable regulatory framework, particularly in the US, is blamed for this. In addition to early and consistent involvement with the sponsor and unique regulatory designations helpful for many CGTs, the U.S. FDA has established a collaborative regulatory method for CGTs. Additionally, the U.S. regulatory approval procedure is expanding and becoming more advantageous for vendors creating CGT products. To speed up the approval procedure, the U.S. FDA has given CGTs the orphan drug category, breakthrough designation, accelerated approvals, and RMAT designations. The region with the fastest CAGR during the forecast period is Asia Pacific. Regenerative medicine-focused biotechnology companies are becoming more prevalent in the Asia Pacific region. Furthermore, the area is expected to continue to hold its position as the hub of cell research and therapy thanks to the steady expansion of destinations for medical tourists including Thailand, Singapore, and India.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Cell And Gene Therapy Clinical Trial Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cell And Gene Therapy Clinical Trial Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Cell And Gene Therapy Clinical Trial Market report scope?

Key Takeaways from this Cell And Gene Therapy Clinical Trial Market Report

• Evaluate Cell And Gene Therapy Clinical Trial market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Cell And Gene Therapy Clinical Trial market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Cell And Gene Therapy Clinical Trial Market?

The Cell And Gene Therapy Clinical Trial Market is growing at a CAGR of 20.5% over the next 5 years.

Who are the key players in Cell And Gene Therapy Clinical Trial Market?

IQVIA, ICON Plc, Covance, PAREXEL International Corporation, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., Syneos Health, Medpace Holdings, Inc., PPD Inc., Novotech, Veristat, LLC, Novartis

What are the significant types of Cell And Gene Therapy Clinical Trial Market?

Phase I, Phase II, Phase III, Phase IV

What are the major end-use applications of Cell And Gene Therapy Clinical Trial Market?

Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases, Dermatology, Endocrine, Metabolic, Genetic, Immunology & Inflammation, Ophthalmology

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.